nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—IL5—autistic disorder	0.788	1	CbGaD
Pranlukast—MUC2—hindbrain—autistic disorder	0.0079	0.113	CbGeAlD
Pranlukast—MUC2—brainstem—autistic disorder	0.00453	0.0648	CbGeAlD
Pranlukast—RNASE3—digestive system—autistic disorder	0.0044	0.0628	CbGeAlD
Pranlukast—MUC2—forebrain—autistic disorder	0.00437	0.0625	CbGeAlD
Pranlukast—MUC2—telencephalon—autistic disorder	0.00402	0.0575	CbGeAlD
Pranlukast—IL5—digestive system—autistic disorder	0.00399	0.0571	CbGeAlD
Pranlukast—NFKB1—mouth—autistic disorder	0.00395	0.0565	CbGeAlD
Pranlukast—MUC2—digestive system—autistic disorder	0.00307	0.0439	CbGeAlD
Pranlukast—NFKB1—eye—autistic disorder	0.00251	0.036	CbGeAlD
Pranlukast—MUC2—head—autistic disorder	0.0025	0.0358	CbGeAlD
Pranlukast—NFKB1—forebrain—autistic disorder	0.00249	0.0356	CbGeAlD
Pranlukast—MUC2—nervous system—autistic disorder	0.00237	0.0339	CbGeAlD
Pranlukast—NFKB1—telencephalon—autistic disorder	0.00229	0.0328	CbGeAlD
Pranlukast—MUC2—central nervous system—autistic disorder	0.00229	0.0327	CbGeAlD
Pranlukast—MUC2—cerebellum—autistic disorder	0.00223	0.0319	CbGeAlD
Pranlukast—MUC2—brain—autistic disorder	0.00181	0.0259	CbGeAlD
Pranlukast—NFKB1—digestive system—autistic disorder	0.00175	0.025	CbGeAlD
Pranlukast—NFKB1—head—autistic disorder	0.00143	0.0204	CbGeAlD
Pranlukast—CYSLTR1—head—autistic disorder	0.0014	0.0201	CbGeAlD
Pranlukast—NFKB1—nervous system—autistic disorder	0.00135	0.0194	CbGeAlD
Pranlukast—CYSLTR1—nervous system—autistic disorder	0.00133	0.019	CbGeAlD
Pranlukast—NFKB1—central nervous system—autistic disorder	0.0013	0.0186	CbGeAlD
Pranlukast—CYSLTR1—central nervous system—autistic disorder	0.00128	0.0183	CbGeAlD
Pranlukast—NFKB1—cerebellum—autistic disorder	0.00127	0.0182	CbGeAlD
Pranlukast—NFKB1—brain—autistic disorder	0.00103	0.0148	CbGeAlD
Pranlukast—CYSLTR1—brain—autistic disorder	0.00102	0.0145	CbGeAlD
Pranlukast—ABCC2—digestive system—autistic disorder	0.000687	0.00982	CbGeAlD
Pranlukast—CYP2C9—digestive system—autistic disorder	0.000458	0.00654	CbGeAlD
Pranlukast—CYP3A4—digestive system—autistic disorder	0.000349	0.00499	CbGeAlD
Pranlukast—CYP3A4—nervous system—autistic disorder	0.00027	0.00386	CbGeAlD
Pranlukast—CYP3A4—central nervous system—autistic disorder	0.00026	0.00372	CbGeAlD
Pranlukast—TNF—Developmental Biology—ITGB3—autistic disorder	2.2e-05	0.000155	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MAPK1—autistic disorder	2.19e-05	0.000154	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1RN—autistic disorder	2.19e-05	0.000154	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTM1—autistic disorder	2.18e-05	0.000153	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—TSC2—autistic disorder	2.17e-05	0.000153	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL5—autistic disorder	2.14e-05	0.000151	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—POMC—autistic disorder	2.14e-05	0.00015	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PRL—autistic disorder	2.13e-05	0.00015	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—autistic disorder	2.12e-05	0.000149	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AVPR1A—autistic disorder	2.12e-05	0.000149	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TSC2—autistic disorder	2.09e-05	0.000147	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	2.09e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-DRB1—autistic disorder	2.08e-05	0.000146	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—autistic disorder	2.07e-05	0.000146	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ACADSB—autistic disorder	2.06e-05	0.000145	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—INPP1—autistic disorder	2.06e-05	0.000145	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—autistic disorder	2.05e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GRM5—autistic disorder	2.05e-05	0.000144	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOE—autistic disorder	2.05e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VIP—autistic disorder	2.05e-05	0.000144	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LEP—autistic disorder	2.05e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ITGA4—autistic disorder	2.04e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—autistic disorder	2.04e-05	0.000144	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADRB2—autistic disorder	2.02e-05	0.000142	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—autistic disorder	2.01e-05	0.000142	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—MAPK1—autistic disorder	2.01e-05	0.000141	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PRKCB—autistic disorder	2e-05	0.000141	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—OXTR—autistic disorder	1.98e-05	0.00014	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	1.98e-05	0.000139	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGF—autistic disorder	1.97e-05	0.000139	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SCT—autistic disorder	1.96e-05	0.000138	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—autistic disorder	1.96e-05	0.000138	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—AVP—autistic disorder	1.95e-05	0.000137	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	1.94e-05	0.000136	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PRKCB—autistic disorder	1.93e-05	0.000136	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—MAPK1—autistic disorder	1.91e-05	0.000135	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—LEP—autistic disorder	1.91e-05	0.000134	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AVP—autistic disorder	1.9e-05	0.000134	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGF—autistic disorder	1.89e-05	0.000133	CbGpPWpGaD
Pranlukast—IL5—Immune System—PTEN—autistic disorder	1.89e-05	0.000133	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF2—autistic disorder	1.89e-05	0.000133	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—MAPK1—autistic disorder	1.88e-05	0.000132	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADM—autistic disorder	1.87e-05	0.000132	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GABBR1—autistic disorder	1.87e-05	0.000132	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PRL—autistic disorder	1.87e-05	0.000131	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APC—autistic disorder	1.85e-05	0.00013	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PIK3CG—autistic disorder	1.85e-05	0.00013	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EIF4E—autistic disorder	1.84e-05	0.00013	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—BTD—autistic disorder	1.84e-05	0.00013	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MET—autistic disorder	1.83e-05	0.000129	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGF—autistic disorder	1.83e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDE4B—autistic disorder	1.83e-05	0.000128	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—autistic disorder	1.79e-05	0.000126	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PLA2G4A—autistic disorder	1.79e-05	0.000126	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—OPRM1—autistic disorder	1.77e-05	0.000124	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—POMC—autistic disorder	1.76e-05	0.000124	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—RORA—autistic disorder	1.76e-05	0.000124	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—autistic disorder	1.74e-05	0.000122	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MEF2C—autistic disorder	1.74e-05	0.000122	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	1.71e-05	0.00012	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ITGB3—autistic disorder	1.69e-05	0.000119	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1—autistic disorder	1.69e-05	0.000119	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	1.69e-05	0.000119	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—MAPK1—autistic disorder	1.68e-05	0.000119	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GZMB—autistic disorder	1.62e-05	0.000114	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SERPINE1—autistic disorder	1.61e-05	0.000113	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BCL2—autistic disorder	1.59e-05	0.000112	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—COMT—autistic disorder	1.59e-05	0.000112	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTP1—autistic disorder	1.58e-05	0.000111	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2A—autistic disorder	1.58e-05	0.000111	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—MAOA—autistic disorder	1.58e-05	0.000111	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—autistic disorder	1.58e-05	0.000111	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	1.57e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1B—autistic disorder	1.57e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—OXT—autistic disorder	1.57e-05	0.00011	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TDO2—autistic disorder	1.56e-05	0.00011	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	1.56e-05	0.00011	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—POMC—autistic disorder	1.56e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—autistic disorder	1.54e-05	0.000109	CbGpPWpGaD
Pranlukast—IL5—Immune System—MAPK1—autistic disorder	1.54e-05	0.000108	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—autistic disorder	1.54e-05	0.000108	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MEF2C—autistic disorder	1.52e-05	0.000107	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—autistic disorder	1.51e-05	0.000106	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TSC2—autistic disorder	1.5e-05	0.000106	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DHCR7—autistic disorder	1.47e-05	0.000104	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—autistic disorder	1.47e-05	0.000104	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LEP—autistic disorder	1.47e-05	0.000103	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOE—autistic disorder	1.47e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD1—autistic disorder	1.46e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSC1—autistic disorder	1.46e-05	0.000103	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTM1—autistic disorder	1.46e-05	0.000102	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—autistic disorder	1.45e-05	0.000102	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	1.44e-05	0.000101	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NTRK2—autistic disorder	1.42e-05	9.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD3—autistic disorder	1.41e-05	9.95e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—EXT1—autistic disorder	1.39e-05	9.82e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC6A8—autistic disorder	1.39e-05	9.82e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PRKCB—autistic disorder	1.39e-05	9.76e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL5—autistic disorder	1.38e-05	9.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-A—autistic disorder	1.38e-05	9.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CALCA—autistic disorder	1.37e-05	9.62e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—INPP1—autistic disorder	1.36e-05	9.58e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ACADSB—autistic disorder	1.36e-05	9.58e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—autistic disorder	1.35e-05	9.52e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DAO—autistic disorder	1.33e-05	9.36e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PIK3CG—autistic disorder	1.33e-05	9.34e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APC—autistic disorder	1.33e-05	9.34e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PTEN—autistic disorder	1.32e-05	9.29e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TSC2—autistic disorder	1.32e-05	9.26e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGF—autistic disorder	1.31e-05	9.23e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—autistic disorder	1.3e-05	9.15e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—autistic disorder	1.29e-05	9.11e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—UPB1—autistic disorder	1.28e-05	8.98e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PTEN—autistic disorder	1.27e-05	8.92e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—POMC—autistic disorder	1.26e-05	8.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DRB1—autistic disorder	1.26e-05	8.87e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—autistic disorder	1.24e-05	8.69e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTEN—autistic disorder	1.22e-05	8.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MAPK1—autistic disorder	1.22e-05	8.56e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1—autistic disorder	1.21e-05	8.55e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PRKCB—autistic disorder	1.21e-05	8.54e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—BTD—autistic disorder	1.21e-05	8.54e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—MAPK1—autistic disorder	1.21e-05	8.51e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRL—autistic disorder	1.21e-05	8.49e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM5—autistic disorder	1.19e-05	8.35e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ASMT—autistic disorder	1.19e-05	8.35e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—autistic disorder	1.18e-05	8.32e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SERPINE1—autistic disorder	1.15e-05	8.12e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGF—autistic disorder	1.15e-05	8.08e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRB2—autistic disorder	1.14e-05	8.06e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC25A12—autistic disorder	1.11e-05	7.85e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC19A1—autistic disorder	1.08e-05	7.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AVP—autistic disorder	1.08e-05	7.57e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MAPK1—autistic disorder	1.07e-05	7.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF2—autistic disorder	1.07e-05	7.54e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TDO2—autistic disorder	1.03e-05	7.26e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—POMC—autistic disorder	1.03e-05	7.24e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PLA2G4A—autistic disorder	1.01e-05	7.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	9.97e-06	7.02e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAPK1—autistic disorder	9.95e-06	7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MEF2C—autistic disorder	9.84e-06	6.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—autistic disorder	9.76e-06	6.87e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—autistic disorder	9.7e-06	6.83e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DHCR7—autistic disorder	9.7e-06	6.83e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADSL—autistic disorder	9.67e-06	6.8e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ITGB3—autistic disorder	9.59e-06	6.75e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—XDH—autistic disorder	9.48e-06	6.67e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—autistic disorder	9.34e-06	6.57e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—autistic disorder	9.33e-06	6.57e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—STX1A—autistic disorder	9.31e-06	6.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NPAS2—autistic disorder	9.31e-06	6.55e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—autistic disorder	9.29e-06	6.54e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2—autistic disorder	9.28e-06	6.53e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MAPK1—autistic disorder	9.26e-06	6.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IFNG—autistic disorder	9.2e-06	6.47e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—EXT1—autistic disorder	9.2e-06	6.47e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC6A8—autistic disorder	9.2e-06	6.47e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TCN2—autistic disorder	8.99e-06	6.33e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—autistic disorder	8.95e-06	6.3e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTEN—autistic disorder	8.78e-06	6.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DAO—autistic disorder	8.77e-06	6.18e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—autistic disorder	8.62e-06	6.07e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADA—autistic disorder	8.57e-06	6.03e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSC2—autistic disorder	8.5e-06	5.98e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	8.47e-06	5.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—UPB1—autistic disorder	8.41e-06	5.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—autistic disorder	8.32e-06	5.86e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—autistic disorder	8.32e-06	5.86e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—autistic disorder	8.28e-06	5.83e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—autistic disorder	8.25e-06	5.81e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—autistic disorder	8.17e-06	5.75e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	8.12e-06	5.71e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—autistic disorder	7.99e-06	5.62e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRKCB—autistic disorder	7.85e-06	5.52e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ASMT—autistic disorder	7.82e-06	5.5e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM5—autistic disorder	7.82e-06	5.5e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—RORA—autistic disorder	7.82e-06	5.5e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTEN—autistic disorder	7.69e-06	5.41e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—autistic disorder	7.64e-06	5.38e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APC—autistic disorder	7.51e-06	5.29e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PIK3CG—autistic disorder	7.51e-06	5.29e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—autistic disorder	7.43e-06	5.23e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGF—autistic disorder	7.42e-06	5.22e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC25A12—autistic disorder	7.35e-06	5.18e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MAOB—autistic disorder	7.33e-06	5.16e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC19A1—autistic disorder	7.15e-06	5.03e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—autistic disorder	7.15e-06	5.03e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK1—autistic disorder	7.14e-06	5.03e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—autistic disorder	7.12e-06	5.01e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	6.97e-06	4.91e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1—autistic disorder	6.88e-06	4.84e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPH2—autistic disorder	6.81e-06	4.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DPYD—autistic disorder	6.7e-06	4.72e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SERPINE1—autistic disorder	6.53e-06	4.6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADSL—autistic disorder	6.38e-06	4.49e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	6.29e-06	4.43e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK1—autistic disorder	6.25e-06	4.4e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—XDH—autistic disorder	6.25e-06	4.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CACNA1C—autistic disorder	6.23e-06	4.38e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—STX1A—autistic disorder	6.14e-06	4.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NPAS2—autistic disorder	6.14e-06	4.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	5.99e-06	4.22e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TCN2—autistic disorder	5.93e-06	4.17e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—autistic disorder	5.73e-06	4.03e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DHFR—autistic disorder	5.67e-06	3.99e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADA—autistic disorder	5.65e-06	3.98e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—autistic disorder	5.49e-06	3.86e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—autistic disorder	5.28e-06	3.72e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—RORA—autistic disorder	5.16e-06	3.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—autistic disorder	5.02e-06	3.53e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTEN—autistic disorder	4.97e-06	3.5e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MAOB—autistic disorder	4.83e-06	3.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—autistic disorder	4.8e-06	3.38e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	4.78e-06	3.36e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPH2—autistic disorder	4.49e-06	3.16e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP19A1—autistic disorder	4.44e-06	3.12e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DPYD—autistic disorder	4.42e-06	3.11e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	4.17e-06	2.93e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—COMT—autistic disorder	4.13e-06	2.9e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CACNA1C—autistic disorder	4.11e-06	2.89e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTP1—autistic disorder	4.11e-06	2.89e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MAOA—autistic disorder	4.1e-06	2.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK1—autistic disorder	4.04e-06	2.85e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CAT—autistic disorder	4e-06	2.81e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G4A—autistic disorder	3.77e-06	2.66e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—autistic disorder	3.77e-06	2.66e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DHFR—autistic disorder	3.74e-06	2.63e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX1—autistic disorder	3.61e-06	2.54e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—autistic disorder	3.34e-06	2.35e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—autistic disorder	3.25e-06	2.28e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—autistic disorder	3.11e-06	2.19e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—autistic disorder	3.11e-06	2.19e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP19A1—autistic disorder	2.93e-06	2.06e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3CG—autistic disorder	2.8e-06	1.97e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—COMT—autistic disorder	2.72e-06	1.92e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTP1—autistic disorder	2.71e-06	1.91e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MAOA—autistic disorder	2.7e-06	1.9e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—autistic disorder	2.67e-06	1.88e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CAT—autistic disorder	2.64e-06	1.86e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—autistic disorder	2.49e-06	1.75e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G4A—autistic disorder	2.49e-06	1.75e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX1—autistic disorder	2.38e-06	1.68e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—autistic disorder	2.2e-06	1.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—autistic disorder	2.13e-06	1.5e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—autistic disorder	2.05e-06	1.44e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTEN—autistic disorder	1.86e-06	1.31e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3CG—autistic disorder	1.85e-06	1.3e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—autistic disorder	1.76e-06	1.24e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—autistic disorder	1.4e-06	9.88e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTEN—autistic disorder	1.22e-06	8.61e-06	CbGpPWpGaD
